Core Laboratories (CLB) AI Stock Analysis

• Market Cap: $761.78M
• Dividend Yield: 0.24%
• Average Volume (3M): 411.26K
• Price to Earnings (P/E): 23.7
• Beta (1Y): 1.27
• Revenue Growth: -1.02%
• EPS Growth: 6.34%
• Country: US
• Employees: 3,400
• Sector: Energy
• Sector Strength: 52
• Industry: Oil & Gas Equipment & Services
• EPS (TTM): 0.22
• Shares Outstanding: 46,563,390
• 10 Day Avg. Volume: 423,711
• 30 Day Avg. Volume: 411,263
• PEG Ratio: -1.70
• Price to Book (P/B): 3.22
• Price to Sales (P/S): 1.55
• P/FCF Ratio: 18.72
• Enterprise Value/Market Cap: 0.78
• Enterprise Value/Revenue: 1.16
• Enterprise Value/Gross Profit: 6.75
• Enterprise Value/Ebitda: 8.18
• 1Y Price Target: $12.00
• Price Target Upside: -26.65% Downside
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 2
• EPS Forecast (FY): 0.73
• Revenue Forecast (FY): $518.27M

• Rating: 72 Outperform
• Price Target: $18.00 ▲(10.02% Upside)

Core Laboratories is on a positive trajectory with strong financial health and technical momentum. The company's strategic initiatives and solid cash flow conversion are significant strengths. However, valuation concerns and external challenges like geopolitical tensions pose risks. Overall, the stock presents a balanced opportunity with potential for growth.

Positive Factors

Strong Financial Health

Improved leverage management enhances financial stability, providing flexibility for strategic investments and resilience against economic downturns.

Strategic Acquisition

The acquisition strengthens Core Lab's market position in Brazil, potentially increasing revenue streams and expanding its technological offerings.

Cash Flow Conversion

Strong cash conversion indicates efficient operations, enabling reinvestment in growth opportunities and shareholder returns through dividends and buybacks.

Negative Factors

Decline in Product Sales

Declining product sales suggest challenges in the U.S. onshore market, potentially impacting revenue growth and requiring strategic adjustments.

Geopolitical Challenges

Ongoing geopolitical tensions create volatility in commodity prices, affecting demand for Core Lab's services and potentially impacting revenue stability.

Flat Year-over-Year Revenue

Flat revenue growth indicates challenges in maintaining momentum, necessitating strategic initiatives to drive future growth and market expansion.

Core Laboratories Business Overview & Revenue Model

Company Description

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.

How the Company Makes Money

Core Laboratories generates revenue through a combination of service contracts, consulting agreements, and the sale of specialized equipment and technologies. The company's primary revenue streams include reservoir description services, which encompass the analysis of reservoir rocks and fluids to help clients optimize hydrocarbon recovery, and production enhancement services that focus on improving the efficiency of existing wells. Additionally, Core Laboratories earns income from its proprietary technologies and products, including advanced tools for reservoir management. Significant partnerships with major oil and gas companies further bolster its revenue, as these collaborations often lead to long-term contracts and recurring business. Market demand for energy and the ongoing need for enhanced production techniques also play crucial roles in driving Core Laboratories' earnings.

Core Laboratories Financial Statement Overview

Summary

Core Laboratories exhibits solid financial health with consistent revenue growth and improving leverage. Profitability margins are stable, though there are slight pressures on EBIT and EBITDA margins. The company has effectively managed its debt levels, enhancing its financial stability. Cash flow metrics indicate strong cash conversion, though operating cash flow coverage could be improved.

Income Statement

Core Laboratories has shown consistent revenue growth, with a TTM growth rate of 2.4%. The company maintains healthy margins, with a gross profit margin of 17.12% and a net profit margin of 6.21% in the TTM. However, there is a slight decline in EBIT and EBITDA margins compared to previous years, indicating potential cost pressures.

Balance Sheet

The company's debt-to-equity ratio has improved significantly to 0.15 in the TTM, indicating better leverage management. Return on equity is strong at 12.24%, reflecting efficient use of equity. However, the equity ratio remains moderate, suggesting room for improvement in asset financing.

Cash Flow

Core Laboratories has demonstrated positive free cash flow growth of 3.92% in the TTM. The operating cash flow to net income ratio is 0.52, showing moderate cash generation relative to net income. The free cash flow to net income ratio is high at 0.91, indicating strong cash conversion, though there is room for improvement in operating cash flow coverage.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	517.50M	523.85M	509.79M	489.74M	470.25M	487.27M
Gross Profit	88.59M	88.37M	94.05M	78.92M	83.84M	102.13M
EBITDA	73.10M	73.27M	70.42M	58.69M	63.78M	70.49M
Net Income	32.12M	31.40M	36.67M	19.45M	19.73M	-97.64M
Balance Sheet
Total Assets	591.36M	590.41M	586.39M	578.35M	580.85M	568.58M
Cash, Cash Equivalents and Short-Term Investments	25.63M	19.16M	15.12M	15.43M	17.70M	13.81M
Total Debt	167.10M	180.14M	215.38M	222.39M	250.26M	326.98M
Total Liabilities	313.97M	332.67M	356.59M	389.40M	419.85M	493.01M
Stockholders Equity	271.35M	251.99M	224.81M	184.26M	156.45M	71.51M
Cash Flow
Free Cash Flow	34.87M	43.36M	14.21M	14.74M	23.04M	45.99M
Operating Cash Flow	50.49M	56.39M	24.79M	24.96M	36.58M	57.87M
Investing Cash Flow	-2.07M	-6.39M	-6.65M	-3.86M	-10.22M	7.85M
Financing Cash Flow	-43.80M	-45.96M	-18.45M	-23.38M	-22.46M	-63.01M

Core Laboratories Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 16.36
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CLB, the sentiment is Positive. The current price of 16.36 is above the 20-day moving average (MA) of 16.35, above the 50-day MA of 15.51, and above the 200-day MA of 12.93, indicating a bullish trend. The MACD of 0.33 indicates Positive momentum. The RSI at 54.93 is Neutral, neither overbought nor oversold. The STOCH value of 58.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CLB.

Core Laboratories Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TTI	77 Outperform	$1.25B	10.16	53.71%	―	0.17%	7307.20%
FTK	76 Outperform	$527.82M	19.67	29.09%	―	23.56%	242.78%
CLB	72 Outperform	$761.78M	23.69	12.31%	0.24%	-1.02%	6.34%
OIS	71 Outperform	$405.07M	18.08	3.31%	―	-11.02%	―
Sector *	65 Neutral	$15.17B	7.61	4.09%	5.20%	3.87%	-62.32%
PUMP	61 Neutral	$962.87M	-55.78	-2.05%	―	-11.65%	87.57%
ACDC	45 Neutral	$678.27M	-1.83	-31.46%	―	-11.92%	-53.72%

Core Laboratories Corporate Events

Core Laboratories Announces Q3 2025 Financial Results

On October 22, 2025, Core Laboratories Inc. announced its third quarter 2025 financial results, highlighting a revenue of $134.5 million, which was up over 3% sequentially but flat year-over-year. The company reported an operating income of $20.9 million and a GAAP EPS of $0.30. Core Lab also completed the acquisition of Solintec, a Brazilian geological services provider, to enhance its capabilities in the South Atlantic Margin. The company repurchased 462,248 shares and declared a quarterly cash dividend, demonstrating its commitment to returning value to shareholders. Additionally, Core Lab’s leverage ratio improved to its lowest level in nine years, indicating strong financial health and strategic positioning for future growth.